Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 219 citing St John Sutton: A comparison of the effects of rosiglitazone and glyburide on cardiovascular.... (0.10 sec) 

Effect of rosiglitazone on the risk of myocardial infarction and death from …

- hopkinsmedicine.org [PDF] 
SE Nissen, K Wolski - New England Journal of Medicine, 2007 - content.nejm.org
From the Cleveland Clinic, Cleveland. Ad- dress reprint requests to Dr. Nissen at the Department
of Cardiovascular Medi- cine, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195, or at
nissens@ccf. org. ... This article (10.1056/NEJMoa072761) was published at ...
Cited by 1339 - Related articles - BL Direct - All 83 versions

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus …


RW Nesto, D Bell, RO Bonow, V Fonseca, SM Grundy, … - Circulation, 2003 - Am Heart Assoc
These beneficial effects of TZDs on glycemia and cardiovascular risk factors have made them
attractive agents in patients with type 2 diabetes who are at high risk for CVD. There is a growing
recognition, however, that edema can occur in patients treated with either drug. Because ...
Cited by 575 - Related articles - BL Direct - All 17 versions

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and …

- ahajournals.org
FA Masoudi, SE Inzucchi, Y Wang, EP Havranek, JAM … - Circulation, 2005 - Am Heart Assoc
Methods and Results— We conducted a retrospective cohort study of 16 417 Medicare beneficiaries
with diabetes discharged after hospitalization with the principal discharge diagnosis of heart
failure. The association between antidiabetic drug prescriptions and outcomes was ...
Cited by 195 - Related articles - All 10 versions

Congestive heart failure and cardiovascular death in patients with prediabetes and …


RM Lago, PP Singh, RW Nesto - The Lancet, 2007 - Elsevier
360 of 20 191 patients who had either prediabetes or type 2 diabetes had congestive heart failure
events (214 with TZDs and 146 with comparators). Results showed no heterogeneity of effects
across studies (I 2 =22·8%; p for interaction=0·26), which indicated a class effect for TZDs. ...
Cited by 181 - Related articles - BL Direct - All 7 versions

Endothelial function, inflammation, and prognosis in cardiovascular disease


MA Gonzalez, AP Selwyn - The American journal of medicine, 2003 - Elsevier
Endothelial dysfunction may be evaluated by means of invasive techniques, such as coronary
artery reactivity to acetylcholine, or noninvasive techniques, such as brachial artery
ultrasonography. Loss of endothelium-dependent vasodilation is a characteristic feature ...
Cited by 127 - Related articles - All 9 versions

Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with …

- onlinejacc.org
WHW Tang, GS Francis, BJ Hoogwerf, JB Young - Journal of the American …, 2003 - Elsevier
We examined 111 consecutive diabetic patients with chronic systolic HF who were treated with
TZD from January 1999 to June 2001. A retrospective chart review was performed to determine
the incidence of fluid retention in this cohort. Physical signs of fluid retention were ...
Cited by 122 - Related articles - BL Direct - All 16 versions

Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and …


G Derosa, AFG Cicero, A Gaddi, PD Ragonesi, E … - Clinical therapeutics, 2004 - Elsevier
Methods: This 12-month, multicenter, double-blind, randomized, controlled, parallel-group trial
was conducted at 3 study sites in Italy. We assessed patients with type 2 DM (duration, ≥6
months) and with metabolic syndrome. All patients were required to have poor glycemic ...
Cited by 118 - Related articles - All 5 versions

Peroxisome proliferator-activated receptor {gamma}: implications for …

- ahajournals.org
WA Hsueh, D Bruemmer - Hypertension, 2004 - Am Heart Assoc
Peroxisome proliferator-activated receptor (PPAR ) is a ligand-activated transcription factor belonging
to the nuclear hormone receptor superfamily. PPAR is expressed by macrophages, endothelial
cells, and vascular smooth muscle cells. It regulates gene expression of key proteins ...
Cited by 109 - Related articles - BL Direct - All 7 versions

A randomized, placebo-controlled trial assessing the effects of rosiglitazone on …

- onlinejacc.org
HJ Dargie, PR Hildebrandt, GAJ Riegger, JJV … - Journal of the American …, 2007 - Elsevier
This study investigated the effects of rosiglitazone (RSG) on left ventricular ejection fraction
(LVEF) in subjects with type 2 diabetes (T2DM) and pre-existing chronic heart failure (CHF)
(New York Heart Association [NYHA] functional class I to II). ... Fluid retention is an ...
Cited by 88 - Related articles - BL Direct - All 13 versions

C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular …


R Nesto - Diabetic medicine, 2004 - pt.wkhealth.com
Increased concentrations of the marker of inflammation, C-reactive protein (CRP), are associated
with insulin resistance, Type 2 diabetes and the development of cardiovascular disease. In
particular, inflammation is closely associated with endothelial dysfunction and is ...
Cited by 84 - Related articles - BL Direct - All 7 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google